Any evaluation of a new mode of therapy for cardiovascular syphilis is bound to yield inconclusive results because of the many unsolved problems in diagnosis, and because of the lack of suitable controls. It is however the author's conviction that in penicillin practitioners have a safe, effective means of supplementing the medical treatment of cardiovascular syphilis.
Evaluation of Treatment
Among the still unsolved problems in the evaluation of penicillin therapy are:
(1) uncertain criteria of diagnosis, clinical and post-mortem, of uncomplicated syphilitic aortitis;
(2) influence of race and sex; (3) prophylactic effect; (4) amount of treatment adequate in early syphilis to prevent the development of cardiovascular complications. Furthermore, insufficient time has elapsed to determine the efficiency of penicillin in the management of cardiovascular syphilis. Evaluation of the effect of penicillin therapy on prognosis is also difficult because we do not know whether or not cardiovascular syphilis is changing with the passage of time, so that we are now seeing a different type of this phase of syphilis. The simultaneous occurrence in patients of cardiovascular and other forms of late syphilis, such as neurosyphilis, may alter the picture of therapeutic efficacy, besides increasing the potential reactivity of the patient to a particular treatment system or drug. Other variable factors involved are: the presence of diabetes mellitus; hypertension; degree of arteriosclerosis; renal function. It is not sufficient merely to use past records to obtain a control series against which to evaluate therapy in cardiovascular syphilis. One cannot be certain whether patients in the previously treated group are similar to those now being subjected to the new method of treatment (Densen and others, 1952) . Barnett and Small (1950) , moreover, on the basis of a series of 334 cases of cardiovascular syphilis with aortic regurgitation, aneurysm, or both, attestto the statistical difficulties in the evaluation of the effect of antisyphilitic therapy in cardiovascular syphilis. They show that symptomatic and asymptomatic cases must be separated for study. In the former, cases observed for less than a year must be eliminated in order to obtain little-and muchtreated groups of comparable initial severity. In the latter, no such elimination can be made, but the results must be expressed in relation to the total years of patient observation, rather than to the number of individual patients involved. Antisyphilitic therapy probably improves prognosis to some extent at any stage of cardiovascular syphilis, but it is definitely more effective when given before the onset of symptoms, and it probably becomes progressively less useful as the disease progresses. Flaum and Thomas (1951) believe that the factors influencing prognosis of cardiovascular syphilis include:
(1) presence or absence of symptoms of diminishing cardiac reserve;
(2) size of heart; (3) age of patient (arteriosclerosis); (4) type of work performed; (5) amount of previous antisyphilitic therapy and when it was given in relation to the discovery of the cardiac involvement. Involved also in the evaluation of cardiovascular syphilis therapy is the relative place of medical care, other than so-called specific therapy. (1949) The study of the effects of therapy on the histopathology of the aorta, however, has yielded contradictory results. While Hood and Mohr (1937) found no histologic differences in the aortas of untreated and adequately treated patients, Howe (1943) and Webster and Reader (1948, 1949) found what appear to be definite differences.
Moore points out certain difficulties in the clinical study of (Moore, 1941) .
Therapeutic Shock and Paradox
In the conventional therapy of cardiovascular syphilis, two concepts, therapeutic shock and therapeutic paradox, played an important role. These problems are fully discussed in " Modern Clinical Syphilology" (Stokes, Beerman, and Ingraham, 1944) , and in papers by Stokes, Wolferth, Edeiken, Falk, and Ford (1951) , Butterly and Fishman (1952) , and Mohr and Hahn (1952) .
Therapeutic Shock.-The former, commonly spoken of as the Jarisch-Herxheimer or Herxheimer reaction, is a flare-up of the disease upon the institution of treatment. Originally described by Jarisch for the secondary eruption under treatment with mercurial inunction, it has been identified in every observable phase of syphilis, early and late. In the use of the arsenicals its intensity up to the point of destructive violence probably depends in part upon the initial intensity and impact of the treatment, though the " allergic " status of the individual also participates in this reaction. Dosage, and the activity of the treatment agent used, both play a role in its production. Its mechanism is still unknown, but the earlier attributing of the flare to lysis of Treponema pallidum at lesion sites is certainly untenable, since the reaction appears after the use of relatively nonspirillicidal drugs, for example, mercury and tryparsamide, and can be seen in lesions of late syphilis in which treponemata are few and far between. It is more probable that at least a part of the reaction is in the cellular tissues and of the nature of an immunity response, or even an allergic reaction. Therapeutic shock induced by metal therapy had to be controlled. This was accomplished by two devices: initial low dosage, and the preliminary use, before the more shock-producing arsenicals were administered, of more or less prolonged " preparation " with the slower-acting heavy metals, although bismuth itself may produce therapeutic shock, and neoarsphenamine can be given without serious clinical shock if the dosage is low enough.
Clinically the Jarisch-Herxheimer reaction may be manifested by increased body temperature as well as by a flare-up of obvious or subclinical syphilitic lesions immediately after treatment with anti-syphilitic agents. In the heart this could result in serious embarrassment. Therapeutic shock, then, has been accepted as a danger in the treatment of cardiovascular syphilis during the middle and later years of the arsenical era, and has discouraged the full use of our therapeutic resources against syphilis in treating the disease in the heart and great vessels. On the other hand, the vasculotoxicity of the arsenicals as such should not be confused with the Jarisch-Herxheimer reaction.
Therapeutic Paradox.-Wile (1922) first described this as the conception that the patient might be injured even fatally by the rapidly induced healing of a syphilitic lesion in a vital structure. This was originally observed in the liver. Syphilitic hepatitis improved rapidly under the arsphenamines, and then with equal rapidity the patient went downhill to uncontrollable ascites, with other evidence of hepatic injury, portal obstruction, and death. Later the concept was broadened to include other late manifestations of syphilis, and supposed fibrous contractile scarring as a phase of the healing process, with shrinkage and distortion of the involved structure, rather than lack of time for functional adjustment, was emphasized as the evil consequence. The mechanism of the therapeutic paradox is still unknown. It may be prevented much in the same way as therapeutic shock. Even substitution of a less toxic arsenical (arsenoxide) may, because of lessened vasculotoxicity, yield fewer' therapeutic paradoxes than the arsphenamines.
Sources of Pertinent Information
For the student of the treatment of cardiovascular syphilis, a number of good sources are available. Among these are: Stokes, Beerman, and Ingraham (1944) , Fleming (1948) , Kampmeier (1946) , Cole and others (1936) , Hinrichsen (1943 ), Woodruff (1948 , de la Chapelle (1947), Nicol (1950) , Cormia (1935 ), Eisenberg (1948 , Chapman and Morgan (1947) , Prebble (1951) , Webster (1947) , Barnett and Small (1950) .
Penicillin in Cardiovascular Syphilis Since penicillin should theoretically behave like the other fast-acting spirillicides, the arsphenamines, it could produce not merely a febrile reaction, but an overall exacerbation of the syphilitic process, transient and serious in proportion to the vital location of the lesion and the size of the initial dose. Early in the penicillin era, workers attempted to control an anticipated shock effect by reduction in dosage, but the observation of Olansky (1947) seemed to indicate that reductions in dosage to as low as 1,000 units were without effect in preventing Herxheimer reactions, though their intensity might conceivably be reduced. Tucker and Farmer (1947) showed that a febrile Herxheimer reaction fails to appear only below such small doses as 1 to 10 units 20 group.bmj.com on January 12, 2018 -Published by http://sti.bmj.com/ Downloaded from PENICILLIN IN CARDIOVASCULAR SYPHILIS kg. body weight. One-tenth of the dose that will render a syphilitic lesion darkfield negative is capable of causing a Jarisch-Herxheimer reaction. Purified crystalline penicillin G appears to yield fewer severe local flares and immediate serious reactions as compared with the arsphenamines. Certain groups (notably at the University of Pennsylvania) have made a complete study of the effects on cardiovascular syphilis, but other investigators have been extremely conservative in their exhibition ofa rapid-acting drug like penicillin, e.g., Wile (1945), Peralta and Castaneda (1949) , Tung (1948) , Eisenberg (1948) , Blomquist (1948) , and Willcox (1951 Schwemlein, 1945; Callaway and others, 1946; Moore, 1949; Scott and others, 1949; Porter, 1948 had received four months of bismuth and iodide therapy before penicillin was administered. Two days after 9-6 million units of penicillin had been given the patient died of rupture of a huge aneurysm. It was evident before treatment that rupture of this aneurysm was imminent and it is impossible to say whether treatment had anything to do with the course of events. In the case presented by Moore the cause of death was likely cardiac failure which developed on the fourth day of treatment. The aorta was filled with plaques of syphilitic aortitis each of which contained fresh hemorrhage. Evaluation in this instance is complicated by the patient's being treated with malaria as well as penicillin. Scott and Maxwell's patient suffered from purulent meningitis of unknown cause. Response to penicillin seemed satisfactory, but the patient died suddenly during convalescence of rupture of a previously unsuspected aneurysm. The possibility of bacterial involvement of the vessel was not discussed.
Of the eight possible reactions there are five reports indicating temporary interference with cardiac function. One of Porter's two patients had received 2 weeks and the other had received 2 months of potassium iodide and bismuth therapy before penicillin was given. Each had aortic insufficiency and one also had an aortic aneurysm. Both were in congestive failure before penicillin was given. As good 'compensation as possible' was obtained by use of digitalis, diuretics, and bed rest, Each developed increasing evidence of congestive failure 2 weeks after penicillin was begun. Each responded satisfactorily to diuretics and greater curtailment of activity. The observation that congestive failure associated with syphilitic aortic insufficiency may be refractory to treatment and that it tends to recur casts some doubt on the conclusion that these patients present evidence of the therapeutic paradox.
Dolkart and Schwemlein's first patient was seen in 1941, at which time diagnoses of latent syphilis and rheumatic heart disease with mitral stenosis and aortic stenosis were made. From 1908 to 1935 the patient had received an unknown amount of arsenic and bismuth. During 1942, an aortic diastolic murmur became evident. On two occasions in 1943, the patient was hospitalized because of chest pain and dyspnea. In 1944, he was again hospitalized and treated for congestive failure. In the summer of 1944, anginal pain on strenuous effort was noted. During 1942 and 1943, fifty doses of bismuth were given. The patient was rehospitalized in September, 1944, for penicillin therapy. Ten thousand units of penicillin given on September 24 produced no reaction. After 20,000 units on September 25, the patient noted four episodes of anginal pain. Twenty thousand units were given again on September 25 and 20,000 units 3 times on September 26. Seven episodes of anginal pain were noted on September 26 and ventricular extrasystoles appeared on physical and electrocardiographic examination. The penicillin was stopped. The extrasystoles disappeared. Because of the associated rheumatic heart disease, the amount of pretreatment, the evident cardiac dysfunction before penicillin was given, it is hazardous to claim that this is an example of a Herxheimer reaction. Whorton and Denham (1951) , who reported the occurrence of a possible Jarisch-Herxheimer reaction after penicillin treatment in a patient with gummatous syphilitic aortitis, also commented on the rarity of the Jarisch-Herxheimer reaction in cardiovascular syphilis, in contrast with early syphilis and central nervous system syphilis.
Encouraged by the relatively lessened reaction tendency of penicillin G over the more crude product, Edeiken and others (1949) , reported the results of the treatment of fifty cases of cardiovascular syphilis with penicillin therapy alone, without preparation; and of twelve patients with cardiovascular syphilis and congestive failure, in whom penicillin and methods to combat congestive failure were used simultaneously. In this group, not only were untoward effects lacking, but the distinct impression prevailed that these patients responded better than most patients with cardiovascular syphilis and decompensation who were treated, as was often the case in the pre-penicillin era, with measures aimed only toward combating congestive failure. Experience with these two groups of cases led to the belief that therapeutic shock in cardiovascular syphilis treated with penicillin is indeed uncommon; and that therapeutic paradox, if it occurs, is a rarity. Various hypotheses, including that of a toxic action of arsenicals upon already diseased tissues, rather than a wholesale sudden liberation of toxic spirochaetal disintegration products, were discussed to explain therapeutic shock. If therapeutic paradox occurs, they do not believe it is common or that it is caused by too rapid cure with disturbance of function and resultant rapid fibrosis.
Subsequently Edeiken and others (1951) reported observations on 111 penicillin-treated cardiovascular syphilitic patients (simple aortitis, 48 ; aortic regurgitation, 51 ; aortic regurgitation and aneurysm, 9; aneurysm, 3), with re-emphasis of the virtual absence of significant therapeutic shock and paradox.
Serologic Effects.-The serologic effects of penicillin therapy on cardiovascular syphilis are bound to be disappointing. The frequent association of neurosyphilis with syphilitic cardiovascular involvement (for example, 45 2 per cent. of the 111 patients mentioned above also had central nervous system syphilis) may account for much of the poor serologic effect of treatment. Edeiken and others (1951) Coale and others (1950) had similarly poor serologic results, and Weir and others (1950) (Johnson and Shapiro, 1951) . However deficient the data, some of the information available on this aspect of the problem is worth mentioning. Coale and others (1950) , for example, noted no striking results, but the overall picture was good.
Flaum and Thomas (1949) stated that seven of their patients with aortic insufficiency, " claimed to be improved after treatment ". This apparent improvement could be due to a general systemic improvement following the eradication of the chronic low-grade syphilitic infection. Leech (1950) reported that all but two of his patients were improved or unchanged. Death in thne was not attributable to treatment.
Chapman and Morgan (1947) observed relief of pain in patients with aneurysm, but their treatment schedule included potassium iodide and bismuth simultaneously.
Wheeler and Curtis (1951) also reported improvement in symptoms, but there were two possible therapeutic paradoxes. Johnson and Shapiro (1951) found significant orthodiagraphic and roentgenographic changes indicating enlargement of an aneurysm in one patient who died of tracheal obstruction 2 days after completion of treatment. Five patients died 2, 270, 350, 537, and 854 days, respectively, after treatment. Most of the patients experienced weight gain and a feeling of well-being. Weir, Roberts, and Tullis (1950) , in a preliminary comparison of the post-treatment with the pretreatment status of their patients, indicated that, although a few patients were graded as " worse " in the post-treatment period, in no case was deterioration hastened by penicillin therapy. Edeiken and others (1951) found that:
penicillin is admirably tolerated by the decompensated heart, with clinical improvement in a high proportion of cases. Anginal pain was relieved without recognizable shock or paradox in four out of five cases. In syphilitic aortitis 'uncomplicated', observed for from 3 to 58 months, one-third were improved, one-half unchanged, and only one-sixth were worse (one death of bronchopneumonia (1949) state that, although a large percentage (50 per cent.) of their cases showed electrocardiographic abnormalities either before, during, or after penicillin treatment, one cannot conclude that they are all directly or solely due to the syphilitic infection. Significant T-wave changes were noted during the course of treatment in eight patients. Moore (1949) observed that tracings taken during the course of treatment did not indicate that penicillin irritated the heart, and in several instances improvement was seen. Peralta and Castaneda (1949) noted that 7-8 per cent. of their patients had altered electrocardiograms. Coale and others (1950) concluded that nothing definite could be concluded by following the electrocardiograms. Johnson and Shapiro (1951) There is evidence to suggest that the course of the disease is favourably influenced by penicillin, but no definite statement can be made before a long follow-up period of at. least 10 years has elapsed, and before a large number of cases have been studied clinically and pathologically.
(5) What effect has treatment on the serologic test for syphilis ?
The information indicates that little may be expected from treatment in the way of serologic reversal. The coincidence of neurosyphilis with the cardiovascular process plays a large role in this lack of serologic reversal.
(6) Should patients with suggestive, but not positive, signs of aortitis be treated with penicillin ? We agree with Edeiken, Ford, and Stokes in saying " yes " to this question. In view of the uncertainties in the diagnosis of uncomplicated syphilitic aortitis and the safe and probable effectiveness of penicillin therapy, the patient should be given the benefit of the doubt, not only because it is practically without danger, but also because it is inexpensive and not time-consuming. In the past, many patients were not treated because even a presumptive diagnosis condemned them to a prolonged, costly, and even dangerous therapeutic regimen.
To these questions may be added:
(7) Is treatment with bismuth and iodides necessary before penicillin therapy of cardiovascular syphilis?
Although, according to Willcox (1951) , most British physicians are employing such preparatory treatment, it is obvious from the data presented above that this seems unnecessary at least from the reaction standpoint. Whether the eventual outcome of treatment will be better with combined therapy or penicillin alone is still unanswered.
Assuming, from the data presented, that penicillin is the safest agent yet produced for treating cardiovascular syphilis, we suggest that the treatment scheme of the University of Pennsylvania group (Edeiken and others, 1951) be employed until a more convenient or effective regimen is evolved.
The advocated treatment includes hospitalization and a 2-hour schedule of crystalline penicillin G (4,800,000 to 9,600,000 units in 40,000 to 80,000 unit individual doses), but procaine penicillin may be given to hospitalized patients on a 600,000 unit single, or a 300,000 unit two-injection daily schedule to an equivalent total dosage. The ambulatory use of this salt is under investigation. By present standards, repetition of courses in excess of two of 9,000,000 units seems unnecessary. . . . The concomitant or subsequent use of heavy metals was not studied in this series, but seems on general experimental grounds to be unnecessary.
